Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Controlled CO2 Inhalation to Increase Blood Pressure in Neurogenic Orthostatic Hypotension: a Proof-of-Concept Novel Therapy Study

NCT06751888 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT06751888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06751888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Controlled CO2 Inhalation to Increase Blood Pressure in Neurogenic Orthostatic Hypotension: a Proof-of-Concept Novel Therapy Study
Lead sponsor
University of Calgary
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 1, 2025
Completion date
December 31, 2028
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurogenic orthostatic hypotension